HOLX officer reports 2,278-share acquisition and 9,681 owned
Rhea-AI Filing Summary
Hologic (HOLX) reported an insider equity change by its officer, the President, Breast & Skeletal. On 11/04/2025, the reporting person acquired 2,278 shares of common stock (code A). The filing notes these relate to performance stock units for which performance criteria were met but that remain subject to service-based vesting, and such units are settled one-for-one in common stock.
Following the reported transaction, the reporting person beneficially owned 9,681 shares directly. This figure includes 346 shares acquired under the employee stock purchase plan since the prior report and 2,327 restricted stock units whose settlement has been deferred under the Issuer’s Deferred Equity Plan.
Positive
- None.
Negative
- None.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Common Stock | 2,278 | $0.00 | $0.00 |
Footnotes (4)
- F1. Represents performance stock units as to which the performance criteria has been satisfied but which remain subject to service-based vesting requirements.
- F2. Performance stock units are settled in shares of common stock on a one-for-one basis.
- F3. Includes 346 shares acquired pursuant to the Issuer's employee stock purchase plan since the date of the Reporting Person's most recently filed Form 4.
- F4. Includes 2,327 restricted stock units, the settlement of which has been deferred pursuant to the Issuer's Deferred Equity Plan.
FAQ
What did HOLX disclose in this Form 4?
What role does the reporting person hold at Hologic (HOLX)?
What are performance stock units (PSUs) in this context?
What additional components are included in the beneficial ownership total?
Was this a direct or indirect holding after the transaction?
AI-generated analysis. How Rhea-AI works. Not financial advice.